Abstract:Mitochondria, widely known as the energy factories of eukaryotic cells, have a myriad of vital functions across diverse cellular processes. Dysfunctions within mitochondria serve as catalysts for various diseases, prompting widespread cellular demise. Mounting research on remedying damaged mitochondria indicates that mitochondria constitute a valuable target for therapeutic intervention against diseases. But the less clinical practice and lower recovery rate imply the limitation of traditional drugs, which need a further breakthrough. Nanotechnology has approached favorable regiospecific biodistribution and high efficacy by capitalizing on excellent nanomaterials and targeting drug delivery. Mitochondria-remedying nanodrugs have achieved ideal therapeutic effects. This review elucidates the significance of mitochondria in various cells and organs, while also compiling mortality data for related diseases. Correspondingly, nanodrug-mediate therapeutic strategies and applicable mitochondria-remedying nanodrugs in disease are detailed, with a full understanding of the roles of mitochondria dysfunction and the advantages of nanodrugs. In addition, the future challenges and directions are widely discussed. In conclusion, this review provides comprehensive insights into the design and development of mitochondria-remedying nanodrugs, aiming to help scientists who desire to extend their research fields and engage in this interdisciplinary subject. Mitochondrial quality decrease, oxidative stress, Ca2+ dyshomeostasis, and inflammation are the major features of multiple types of diseases of mitochondrial damage. Mitochodnria-remedying nanodrugs with different characteristics and remarkable brilliance are committed to ameliorating various diseases by rescuing mitochondria via repairing mitochondrial quality, protecting mitochondria from oxidative stress, inhibiting mPTP and inflammation response and mitochondrial bionics. image

Revitalizing Ancient Mitochondria with Nano-Strategies: Mitochondria-Remedying Nanodrugs Concentrate on Disease Control

Therapeutic and tampering approaches for mitochondrial associated diseases

Cell Models and Drug Discovery for Mitochondrial Diseases

Advancements in Mitochondrial-Targeted Nanotherapeutics: Overcoming Biological Obstacles and Optimizing Drug Delivery

Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases

Targeting mitochondrial quality control: new therapeutic strategies for major diseases

Mitochondrial dysfunction-targeted nanosystems for precise tumor therapeutics

Nanozymes targeting mitochondrial repair in disease treatment

Targeted Mitochondrial Nanomaterials in Biomedicine: Advances in Therapeutic Strategies and Imaging Modalities

Mitochondrial dysfunction: mechanisms and advances in therapy

Mitochondria-Targeted Nanomedicine for Enhanced Efficacy of Cancer Therapy

Mitochondria targeting drugs for neurodegenerative diseases—Design, mechanism and application

Recent advances in mitochondria-targeting theranostic agents

Mitochondria‐targeted Nanoparticles in Treatment of Neurodegenerative Diseases

Mitochondria-Targeting Chemodynamic Therapy Nanodrugs for Cancer Treatment

[Mitochondrial therapy: a new strategy for treating mitochondrion-associated diseases]

Recent Advancements in Mitochondria-Targeted Nanoparticle Drug Delivery for Cancer Therapy

Mitochondria-Targeted Drugs

Mitochondrial-Targeted Drug and DNA Delivery

Unraveling mitochondria‐targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials